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1. Introduction 
The discovery of carbon nanotubes (CNTs) promised to revolutionize biomedical research 
by offering unique performance attributes inherent in their unique mechanical, electrical, 
optical and magnetic properties [1-6]. CNTs are highly anisotropic cylindrical 
nanostructures with lengths ranging from several hundred nanometres to several 
micrometres, and diameters of 0.4–100 nm. CNTs can be classified as single-walled carbon 
nanotubes (SWNTs) or multi-walled carbon nanotubes (MWNTs), depending on the 
number of graphene layers which compose its structure.  
CNTs are typically prepared using one of three methods: laser ablation [7], arc-discharge [8], 
and chemical vapor deposition (CVD) [9]. CVD, the most popular pathway of production, 
involves reacting a metal catalyst (such as nickel, cobalt with a hydrocarbon feedstock at 
high temperatures (>800°C) to produce CNT. Both SWNTs and MWNTs, are commercially 
available in varying degrees of purity. Pristine CNT (non-purified and/or non-
functionalised) are completely insoluble in all solvents -- a property which has generated 
some health concerns in terms of toxicity [10]. Therefore the functionalization of CNT is a 
key step towards novel biomedical applications. Advanced methods to chemical 
modification and functionalization have enabled solvation and dispersal of CNTs in water 
[11-13]. Properly functionalized CNT have a high propensity to cross cell membranes. 
Various functionalized SWNTs have been shown to transport various bio-molecules across 
into living cells without cytotoxicity [14, 15]. Nanospearing or nanopenetration molecular 
delivery, which relies on the penetration of magnetic carbon nanotubes (mCNTs) into cells 
by magnetic field exposure, was also recently suggested by Cai et al [3]. In this technique, a 
rotating magnetic field first guided CNTs to spear the cells. In a second step, a static field 
pulled CNT into the cells. The researchers have achieved unprecedented high molecular 
delivery efficiency into difficult-to-transfect cells such as primary mammalian neurons and 
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B lymphocytes with high viability after transfection. In addition to providing a successful 
molecular delivery platform, CNTs have been also used for successful cellular 
labelling/tracking in recent years. CNTs coated with peptides have been reported to be 
successfully delivered and imaged in living human cervical cancer HeLa cells [16]. More 
interestingly, CNT fluorescence was detected and imaged from living Drosophila larva by 
using near-infrared (NIR) with no adverse effects on the viability and growth of the larva 
[17]. These recent findings prompted our group to investigate CNT-mediated labelling 
platforms for stem cell tracking. 
One of potential applications of nanotechnologies in stem cell research is the noninvasive 
tracking of stem cells and progenitor cells transplanted in vivo. Hematopoietic 
stem/progenitor cells (HSPC) are the most common type of stem cells used for cellular 
therapies for many decades [18]. Transplantation of HSPC obtained from peripheral blood 
(PB), bone marrow (BM) or from umbilical cord blood (CB) has been routinely used to 
rescue bone marrow function following high-dose chemotherapy for non-malignant and 
malignant hematologic disorders such as leukemias [19, 20]. Labelling HSPC and the 
consecutive non-invasive tracking in vivo following transplantation have become important 
in understanding HSPC homing/engraftment into BM and the therapeutic efficacy for 
future stem-cell-based therapies. The fate of transplanted stem cells or progenitor cells is 
generally assessed by labelling them in vitro with a fluorescent dye, thymidine analog, 
transfected gene such as LacZ, or green fluorescent protein (GFP). However, the 
methodology for real-time tracking of HSPCs in vivo is still lacking, which seriously restricts 
the progress of research. This chapter describes the evaluation of the uptake efficiency of 
fluorescein-isothiocyanate-labelled functionalized mCNT (FITC-mCNT) into HSPC and 
their effect on the HSPC properties.   
2. Materials and methods 
2.1 Source and isolation of human CD34+ HSPC 
Peripheral blood leukapheresis product (LP) was obtained with the patients’ informed 
consent (in accordance with the institutional guidelines approved by the Human Research 
Ethic Board of the University of Alberta) before cryopreservation. CB was collected 
immediately after delivery in a sterilized tube containing heparin (1000 IU/ml), and with 
the informed consent of the mother (in accordance with the institutional guidelines 
approved by the Health Research Ethics Board of the University of Alberta). Light density 
cells from CB and LP were obtained by Percoll density gradient centrifugation and enriched 
for CD34+ cells by immunoaffinity selection with MACS paramagnetic beads (Miltenyi 
Biotec, Auburn, CA, USA), according to the manufacturer’s instructions [21]. The purity of 
isolated CB and LP CD34+ cells were >95% and >91%, respectively, as determined by 
fluorescence-activated cell sorter (FACS) analysis.  
2.2 Synthesis of FITC-mCNT 
Single-walled mCNT containing Ni and Y at the tip, with an average diameter of 1.2–1.5 nm 
and a length of 2–5 μm, were obtained from Sigma-Aldrich (Ontario, Canada). These specific 
mCNT were chosen for our experiment because they have been used in magnetic-field-
driven biomolecule delivery with very high efficiency [3]. Compared to the reported 
methods, our synthesis of FITC-mCNT is much simpler and yet returns higher chemical 
yields [11]. As shown in figure 1, the mCNTs were oxidized to form carboxylic acid groups 
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on the surface [3, 11, 22-24], which were reacted with thionyl chloride and then 2_-
(ethylenedioxy)bis(ethylamine) to produce amine terminated nanotubes. The amine was 
then reacted with FITC to provide FITC-labelled highly water-soluble FITC-mCNT. Infrared 
(IR), X-ray photoelectron spectroscopy (XPS) and UV–vis spectroscopy were used to 
validate the chemical reactions of the intermediate and the final FITC-mCNT products. 
1. Oxidation of the carbon nanotubes: The first oxidation step was carried out as described 
previously [3, 11, 22-24]. Briefly, the purchased carbon nanotubes (200 mg) were refluxed 
with 0.5 M HNO3 (100 ml) for 48 h to introduce carboxylic groups. After refluxing, the 
solution was diluted with deionized water, filtered over a 0.2 μm polycarbonate filter 
(Millipore) and washed several times with deionized water. The sample was collected and 
dried overnight in a vacuum oven at 80 ℃ to obtain mCNT 2 (170 mg) (figure 1). 
 
 
Fig. 1. Schematic illustration of FITC-mCNT synthesis. (1) The mCNTs were oxidized to 
form carboxylic acid groups on the surface. (2) These nanotubes were reacted with thionyl 
chloride, (3) and then 2_-(ethylenedioxy)bis(ethylamine) to produce amine-terminated 
nanotubes. (4) The amine was then reacted with FITCs to form highly water-soluble FITC-
mCNTs. (5) Freshly synthesized fluorescent and magnetic FITC-mCNTs were then used in 
magnetic-field-driven HSPC uptake experiments. 
FITC-mCNT
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2. Reaction with thionyl chloride to give SWNT-COCl: A suspension of mCNT 2 (100 mg) in 
20 ml of SOCl2, together with five drops of dimethylformamide (DMF), was stirred at 70 
◦C for 24 h. The mixture was cooled and centrifuged at 2000 rpm for 30 min. The excess 
SOCl2 was decanted and the resulting black solid was washed with anhydrous THF (3 × 
20 ml) and dried overnight in a vacuum oven at 80℃ to give mCNT 3 (78 mg) (figure 1). 
3. Coupling with 2-(2-(2-aminoethoxy)ethoxy)ethan amine: The mixture of mCNT 3 (50 
mg) and anhydrous 2-(2-(2-aminoethoxy)ethoxy)ethanamine (120 ml) was heated at 100 
◦C for 100 h. During this time, the liquid phase became dark. After cooling, the mixture 
was poured into methanol (100 ml) and centrifuged to give a black solid, which was 
washed several times with methanol. The resulting solid was dried overnight in a 
vacuum oven at 80 ◦C to give mCNT 4 (42 mg) (figure 1). 
4. Labeling with FITC: A suspension of the mCNT 4 (25 mg) and FITC (5 mg) in 
anhydrous DMF (10 ml) was stirred in the dark for 5 h. Then the reaction mixture was 
poured into anhydrous ethyl ether (40 ml) and centrifuged to give a black solid, which 
was washed with methanol until TLC (10% MeOH in dichloromethane) showed no free 
FITC left. The product was dried overnight in a vacuum oven at 80 ℃ to give mCNT 5 
(23 mg) (figure 1). 
2.3 Magnetic-field driven HSPC uptake of FITC-mCNT 
CD34+ cells with a density of 2.5 to 3*105 cells/plate were placed in poly-L-lysine (10 μg/ml)-
coated p35 mm culture dishes and incubated for 45 min at 37 °C, 5% CO2. The magnetic-
field-driven delivery method was applied as previously described [3]. Culture dishes were 
vertically placed into a beaker containing 50 ml serum-free IMDM media with different 
concentrations of FITC-mCNT or mCNT (10, 20 and 40 μg/ml) and then the beaker was 
placed on a magnetic stirrer set up at 1200 rpm for 10 min. Culture dishes were then 
transferred to an Nd–Fe–B permanent magnet for another 10 min. The uptake experiment 
was terminated by washing the cells with PBS and the cells were incubated for 1, 3, 6, 24 and 
48 h at 37◦C, 5% CO2 for uptake efficiency of FITC-mCNT. 
 
 
Fig. 2. Schema of magnetic-filed driven delivery method.  
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2.4 FACS analysis 
The cells exposed to FITC-mCNT at different time points and concentrations were collected, 
extensively washed and then fixed in 1% paraformaldehyde prior to FACS analysis 
(FACscan, Becton-Dickinson, San Jose, CA, USA) to determine uptake efficiencies. 
2.5 Confocal microscopy 
CD34+ cells were seeded at a density of 1*105 cells/cm2 on cover slips previously coated 
with poly-L-lysine (10 μg/ml) for 45 min at 37 ◦C, 5% CO2. The cells exposed to 40 μg/ml 
FITC-mCNT and mCNT (the control) with the nanotube spearing method. Uptake was 
terminated by washing the cells twice with ice-cold PBS. After 1, 3 and 6 h incubation, the 
cells were fixed in 3.7% paraformaldehyde, stored overnight at 4 °C and examined under an 
inverted confocal laser scanning microscope (Carl Zeiss LSM510, Toronto, Canada) 
equipped with imaging software (LSM 5 Image Browser, Carl Zeiss). 
2.6 Cell viability 
Cell viability was measured by the trypan blue exclusion assay. CD34+ cells were collected 
and pelleted by centrifugation at 700 g for 5 min. The cells were re-suspended in 25 µl 
phosphate buffered saline (PBS), mixed with 5 µl of 0.4% trypan blue solution and counted 
using a hemocytometer. 
2.7 Colony-forming unit (CFU) assay 
After exposure to the FITC-mCNT solution with a concentration of 40 μg ml−1 for 1, 3 and 6 
h, CD34+ cells were plated in triplicate in standard semisolid methylcellulose 
haematopoietic progenitor culture media (human MethoCult GF; Stem Cell Technologies, 
Vancouver, BC, Canada) at concentrations of 1*103 /ml These culture plates were incubated 
at 37 ◦C in 5% CO2. Colonies were identified and enumerated 14 days later. 
3. Results and discussion 
In the present study, we examined the magnetic-field-driven uptake of FITC-mCNT into 
HSPC. FITC-mCNT with both fluorescent and magnetic properties were synthesized and 
freshly prepared for our uptake experiments as summarized in figure 1. In order to test our 
fluorescent and magnetic FITC-mCNTs for labelling HSPC, CD34+  cells obtained from LP 
were exposed to solutions of different concentrations of FITC-mCNT or mCNT alone (10, 20 
and 40 μg/ml) in the presence of a magnetic field. The uptake efficiencies of these cells were 
determined using FACS 1, 3 and 6 h after the uptake. In LP CD34+ cells, the FITC-mCNT 
uptake started (45% FITC uptake) 1 h after exposure even at the lowest FITC-mCNT 
concentration (10 μg/ml and reached its maximum efficiency (83% FITC uptake) after 6 h 
(figure 3(A)).  
FITC reached 83%, 90% and 100% in LP CD34+ cells at 6 h after uptake of FITC-mCNT with 
10, 20 and 40 μg/ml concentrations, respectively. Although LP CD34+ cells were ~100% 
FITC-positive at 3 and 6 h after uptake of FITC-mCNT (40 μg/ml), the mean fluorescence 
(MF) was the highest at 6 h after FITCmCNT uptake (figure 3(B)), which indicates more 
uptake of FITC-mCNT into CD34+ cells as time increases. Therefore, we further investigated 
the internalization of the highest concentration of FITC-mCNT (40 μg/ml) into these cells at 
24 and 48 h after uptake. LP CD34+ cells were still about 98% FITC-positive 24 and 48 h after 
FITC-mCNT uptake, though their MF significantly dropped compared to that at 6 h (figure 
4), most likely due to FITC degradation over time. 
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Fig. 3. Efficient uptake of FITC-mCNTs in LP HSPC as shown by FACS analysis. (A) % FITC 
of LP CD34+ cells exposed to increasing concentrations of FITC-mCNTs or mCNTs (10, 20 
and 40 μg/ml) at 1, 3 and 6 h after exposure. (B) Mean fluorescence  of LP CD34+ cells 
exposed to FITC-mCNT (40 μg/ml) at 1, 3 and 6 h after delivery. 
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Fig. 4. % FITC and MF of LP CD34+ exposed to FITC-mCNT (40 μg/ml) 24 and 48 h after 
delivery. 
To confirm that even less mature HSPC can efficiently uptake FITC-mCNT, we next studied 
the internalization of FITC-mCNT (40 μg/mlinto CB-derived HSPC containing a larger 
immature stem cell fraction (CD34+, CD38−phenotype) than LP HSPC. The efficient uptake 
started after about 1 h in CB CD34+ cells as demonstrated by ~40% FITC uptake rate shown 
in figure 5(A), which was lower compared to the result in LP CD34+ cells. FITC-mCNT 
uptake reached 90% about 6 h after its exposure to the cells, similar to the result in LP CD34+ 
cells, based on the FACS analysis (figure 5(A)). Confocal analysis also confirmed the 
efficient internalization of FITC-mCNT into CB CD34+ cells (figure 5(B)), similar to confocal 
data obtained in THP-1 and MCF-7 cells [25]. FITC-mCNT uptake was saturated at 6 h after 
its exposure to CB CD34+ cells similar to LP CD34+ cells (figure 5(B)). However, we did not 
observe a fluorescence signal by confocal analysis 1 h after FITC-mCNT exposure to cells, 
most probably due to a weak fluorescence signal (data not shown). The HSPC that were not 
exposed to FITC-mCNT (or the control) did not show any evidence of green fluorescence by 
confocal analysis, which is consistent with the FACS data in figure 5(B). These data suggest 
that FITC-mCNT are efficiently internalized by HSPC in a time and concentration-
dependent manner. In addition, this efficient mCNT delivery method does not depend on a 
targeted cell type because this method employs a physical magnetic force for delivery, 
unlike a biological mechanism like viral. Compared with other nanomaterial uptake using 
native or modified supermagnetic iron oxide (SPIO) [26, 27], FITC-mCNT labelling or 
uptake is more efficient for stem cell labelling. 
Our rapid FITC-mCNT labelling of HSPC might offer a solution for the difficulty of tracking 
the movement of transplanted HSPC in patients. 
To investigate the cytotoxicity of mCNT, we studied the HSPC viability after FITC-mCNT 
uptake by trypan blue exclusion assay. With the exposure of FITC-mCNT to various 
concentrations (10, 20 and 40 μg/ml, the viability of LP CB CD34+ cells was not 
compromised compared to the control even 6 h after delivery when the uptake rate reached 
its peak in these cells (figure 6(A)). As expected, the viability of CB CD34+ cells was also not 
affected by the uptake of FITC-mCNT (figure 6(B)).  
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Fig. 5. FITC-mCNTs are also taken up effectively into CB HSPC. (A) % FITC of CB CD34+ 
cells labelled with FITC-mCNT (40 μg/ml). (B) Confocal microscopy of FITC-mCNT-
labelled CB CD34+ cells at 3 and 6 h after delivery. Blue (DAPI): nucleus. 
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Fig. 6. FITC-mCNTs show no adverse effect on cell viability of HSPC cell count of FITC-
mCNT-labelled (A) LP CD34+ cells and (B) CD34+ cells 
It has been reported that CNT has no adverse effect on macrophages. It was also not 
cytotoxic and has no significant effect on adipogenic, osteogenic or chondrogenic 
differentiation of hMSC [28]. To investigate the long-term cytotoxicity effect of our 
magnetic-field-driven FITC-mCNT uptake and their impact on the differentiation of HSPC, 
we performed a colony unit assay (CFU) on FITC-mCNT-labelled HSPC 1, 3 and 6 h after 
uptake. After 14 days, colonies were identified and enumerated. No evidence was observed 
of cytotoxicity nor was the differentiation affected in FITC-mCNT labelled HSPC because 
there was no difference in overall colony number or type (CFU-GM: colony-forming unit of 
granulocyte/macrophage; BFU-E: burst forming unit of erythrocyte; CFU-GEMM: colony-
forming unit of granulocyte macrophage-erythroid megakaryocyte) between the FITC-
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mCNT labelled and the control HSPC (figure 7). These observations suggest that FITC-
mCNT internalization is not only efficient and safe, but it also does not alter the HSPC’s 
properties, similar to the effect of COOH-functionalized single-walled CNT in human 
mesenchymal stem cells [28]. 
 
 
Fig. 7. Internalization of FITC-mCNTs did not affect the differentiation of HSPC. Colony-
formation unit of FITC-mCNT-labelled HSPCs at 1, 3 and 6 h after the internalization by 
clonogenic assay. 
3. Conclusion and future outlook 
In the current study, a highly efficient and safe mCNT-mediated labelling method for stem 
cells has been presented. For the efficacy of future stem cell-based therapies, it is crucial to 
image stem cells and their final location in vivo. Detection by magnetic resonance imaging 
(MRI) may serve as a noninvasive in vivo method to study the fate of transplanted stem cells 
labelled with magnetic nanoparticles. However, the detection of mCNT by standard MRI 
would be difficult due to its low resolution. Thus, mCNT modified with a contrast agent 
such as gadolinium chelates could be used for in vivo detection and tracking of stem cells 
using MRI. A promising new approach to non-invasive imaging by exploiting the near-
infrared (NIR) optical properties of mCNT might also create significant advances for in vivo 
monitoring of transplanted stem cells.  In addition to their use for stem cell labelling and 
tracking, mCNT could also serve as a perfect platform to deliver genes into hard-to-transfect 
stem cells. Many strategies for enhancing stem cell transplantation, proliferation and 
differentiation require the delivery of biomolecules into the cytosolic or nuclear 
compartments. However, transfection efficiency in stem cells is very low -- a consequence of 
the low division frequency of the target cells and the quiescent nature of most primitive 
stem cells. Though viral vectors are capable of efficiently transporting recombinant DNAs 
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into a cell, the undesirable consequences of a viral integration process (i.e. haphazard 
activation or silencing of host genes), as well as the immunogenicity of viral particles, have 
recently raised safety concerns about viral vectors [29]. mCNTs that cross the cell membrane 
through mechanisms other than endocytosis might be an interesting approach to deliver 
biomolecules within stem cells. Therefore, systemic studies must assess the toxicological 
impacts of nanotubes on a biological system and evaluate the effects of CNT on the function 
of stem cells in vivo.  
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